Director/PDMR Shareholding

RNS Number : 0863J

Allergy Therapeutics PLC

24 March 2010

 



Wednesday 24 March 2010

Allergy Therapeutics plc

('Allergy Therapeutics' or the 'Company')

Director/PDMR Shareholding

Allergy Therapeutics announces that on 23 March 2010 Mr Ian Postlethwaite, a director of the Company, exercised share options over 1,000,000 ordinary shares of 0.1 pence each ('Ordinary Shares') awarded pursuant to the Allergy Therapeutics 2001 Share Option Plan as follows:

Name of scheme:                                Allergy Therapeutics 2001 Share Option Plan

Date of grant:                                      17 December 2002

Date of exercise:                                 23 March 2010

Exercise price:                                    0.1 pence

Number of shares exercised:                1,000,000

On the same day, Mr Postlethwaite sold 507,000 Ordinary Shares at an average trade price of 13.1 pence per share to fund tax and costs due on the exercise of these options.

Following the above transactions, Mr Postlethwaite now holds share options over 2,063,500 Ordinary Shares and LTIPs over 769,691 Ordinary Shares. As a result of this exercise, Mr Postlethwaite holds 493,000 Ordinary Shares (representing 0.2 per cent. of the total voting rights of the Company).

Application has been made for the admission to trading on AIM ("Admission") of 1,000,000 Ordinary Shares with Admission expected to take place on 29 March 2010.

For further information

Allergy Therapeutics	[phone]
Manuel Llobet, Chief Executive Officer
www.allergytherapeutics.com
Nomura Code Securities	[phone]
Juliet Thompson/ Chris Golden

 

END

 

 

RDSGIGDXIUDBGGS